Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann T Farrell

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Oncologist|December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemiaFiroozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid LeukemiaEmily Y Jen, Chia-Wen Ko, Jee Eun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmEmily Y Jen, Xin Gao, Liang Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2021
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level AnalysesKelly J Norsworthy, Xin Gao, Chia-Wen Ko, et al.
Leukemia|June 11, 2020
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysisKelly J Norsworthy, Armen Avagyan, Steven T Bird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2014
U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemiaHyon-Zu Lee, Barry W Miller, Virginia E Kwitkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
FDA Approval: BlinatumomabDonna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
The Oncologist|July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public HealthElaine Chang, Lorraine Pelosof, Steven Lemery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myelomaThomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Oncologist|December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemiaFiroozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid LeukemiaEmily Y Jen, Chia-Wen Ko, Jee Eun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmEmily Y Jen, Xin Gao, Liang Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2021
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level AnalysesKelly J Norsworthy, Xin Gao, Chia-Wen Ko, et al.
Leukemia|June 11, 2020
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysisKelly J Norsworthy, Armen Avagyan, Steven T Bird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2014
U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemiaHyon-Zu Lee, Barry W Miller, Virginia E Kwitkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
FDA Approval: BlinatumomabDonna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
The Oncologist|July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public HealthElaine Chang, Lorraine Pelosof, Steven Lemery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myelomaThomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Pageof 6